Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity

Vaccine-elicited adaptive immunity is an essential prerequisite for effective prevention and control of coronavirus 19 (COVID-19). Treatment of multiple sclerosis (MS) involves a diverse array of disease-modifying therapies (DMTs) that target antibody and cell-mediated immunity, yet a comprehensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabatino, Joseph J., Mittl, Kristen, Rowles, William, Mcpolin, Kira, Rajan, Jayant V., Zamecnik, Colin R., Dandekar, Ravi, Alvarenga, Bonny D., Loudermilk, Rita P., Gerungan, Chloe, Spencer, Collin M., Sagan, Sharon A., Augusto, Danillo G., Alexander, Jessa, Hollenbach, Jill A., Wilson, Michael R., Zamvil, Scott S., Bove, Riley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475959/
https://www.ncbi.nlm.nih.gov/pubmed/34580672
http://dx.doi.org/10.1101/2021.09.10.21262933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475959/
https://www.ncbi.nlm.nih.gov/pubmed/34580672
http://dx.doi.org/10.1101/2021.09.10.21262933

Ejemplares similares